← Evidence map

ArticleGene therapy2001

Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery.

M Tanaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2001

…

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

this papercites it

Connexin 26 enhances the bystander effect in HSVtk/GCV gene therapy for human bladder cancer by adenovirus/PLL/DNA gene delivery. | OpenQuestion